Genor Biopharma Holdings Ltd.

21
Strong Sell
  • Market Cap: N/A
  • Industry: Pharmaceuticals & Biotechnology
  • ISIN: KYG3871A1004
HKD
1.88
-0.14 (-6.93%)
  • Price Points
  • Score
  • Mojo Parameters
  • Total Return
  • News and Corporate Actions
  • Key factors
  • Shareholding
  • Financials
  • CompanyCV
stock-recommendationCash Flow
Genor Biopharma Holdings Ltd. Cash flow Statement
Figures in Million
Consolidated Cash Flow Results
Dec'25
Dec'24
Dec'23
Dec'22
Dec'21
Dec'20
No of Months
12
12
12
12
12
12
Profit Before Tax
538.00
523.00
-748.00
-851.00
-1,044.00
-3,411.00
Adjustment
0.00
0.00
0.00
0.00
0.00
0.00
Changes In working Capital
-402.00
-9.00
-6.00
90.00
34.00
-242.00
Cash Flow after changes in Working Capital
0.00
0.00
0.00
0.00
0.00
0.00
Cash Flow from Operating Activities
286.00
716.00
-469.00
-675.00
-752.00
-881.00
Cash Flow from Investing Activities
910.00
-216.00
6.00
-15.00
-65.00
-110.00
Cash Flow from Financing Activities
-598.00
-462.00
-7.00
-65.00
22.00
4,200.00
Net Cash Inflow / Outflow
594.00
43.00
-467.00
-713.00
-878.00
3,009.00
Opening Cash & Cash Equivalents
0.00
0.00
0.00
0.00
0.00
0.00
Cash & Cash Equivalent on Amalgamation / Take over / Merger
0.00
0.00
0.00
0.00
0.00
0.00
Cash & Cash Equivalent of Subsidiaries under liquidations
0.00
0.00
0.00
0.00
0.00
0.00
Translation adjustment on reserves / op cash balances foreign subsidiaries
0.00
0.00
0.00
0.00
0.00
0.00
Effect of Foreign Exchange Fluctuations
-4.00
5.00
3.00
41.00
-82.00
-199.00
Closing Cash & Cash Equivalent
0.00
0.00
0.00
0.00
0.00
0.00
Figures in HKD Million
Seasonal companies are compared with the same quarter last year
Compare Cash Flow Results of Genor Biopharma Holdings Ltd.
Markets Mojo
Figures in Million
consolidated Cash Flow Results
Markets Mojo
Markets Mojo
Change(HKD)
Change(%)
Profit Before Tax
538.212075095034
-598.900918397302
1,136.00
189.87%
Adjustment
0
0
0.00
0.00%
Changes In working Capital
-402.493735959434
68.0592641296984
-470.00
-691.39%
Cash Flow after changes in Working Capital
0
0
0.00
0.00%
Cash Flow from Operating Activities
286.673147106483
-94.3166594582636
380.00
403.95%
Cash Flow from Investing Activities
910.890094546562
-1.61377077563527
911.00
56544.83%
Cash Flow from Financing Activities
-598.472531665866
-173.19295968755
-425.00
-245.55%
Net Cash Inflow / Outflow
594.194086968366
-275.8040538851
869.00
315.44%
Opening Cash & Cash Equivalents
0
0
0.00
0.00%
Cash & Cash Equivalent on Amalgamation / Take over / Merger
0
0
0.00
0.00%
Cash & Cash Equivalent of Subsidiaries under liquidations
0
0
0.00
0.00%
Translation adjustment on reserves / op cash balances foreign subsidiaries
0
0
0.00
0.00%
Effect of Foreign Exchange Fluctuations
-4.89662301881265
-6.68066396365137
2.00
26.70%
Closing Cash & Cash Equivalent
0
0
0.00
0.00%
Cash Flow - Snapshot (Consolidated) - Dec'25
stock-summary

YoY Growth in year ended Dec 2025 is -60.01% vs 252.59% in Dec 2024

Dec'25
Dec'24
Change(%)
Cash Flow from Operating Activities
286.67
716.81
-60.01%